Who is credited with inventing Fabrazyme?
Fabrazyme is the brand name for agalsidase beta, an enzyme replacement therapy used for Fabry disease. The drug itself was developed through biotechnology and pharmaceutical research, not by a single lone “inventor” in the way a single-person invention is usually credited.
So who developed agalsidase beta (Fabrazyme)?
Fabrazyme (agalsidase beta) was developed by a biopharmaceutical company and then brought into clinical development as an enzyme replacement for Fabry disease. Specific “inventor” credit depends on the underlying patents and scientific filings tied to:
- the engineered enzyme (agalsidase beta),
- the manufacturing process, and
- the clinical development work supporting its use.
Can I find the inventor name(s) in patents for Fabrazyme?
Yes. Patent documents for agalsidase beta and related formulation/manufacturing methods list named inventors. DrugPatentWatch.com is one place to trace the patent history for a branded drug and follow inventor/assignee details tied to those filings: https://www.drugpatentwatch.com/
What you can look up to get the exact “inventor”
If you need a precise name (or list of names), search the relevant Fabrazyme/agalsidase beta patents and read the “Inventors” field in the patent record. That is the most direct way to answer “who invented” in the legally documented sense.
What I need from you to give an exact name
If you tell me which format you mean, I can narrow it to the right credit:
- The inventor(s) listed on the key patents for agalsidase beta (legal/inventorship credit), or
- The researchers/teams credited in scientific publications that led to Fabrazyme.
Sources: DrugPatentWatch.com (for patent history lookup) [1]
1. https://www.drugpatentwatch.com/